CAPA in the Pharmaceutical and Biotech Industries

CAPA in the Pharmaceutical and Biotech Industries
Author :
Publisher : Elsevier
Total Pages : 250
Release :
ISBN-10 : 9781908818379
ISBN-13 : 1908818379
Rating : 4/5 (379 Downloads)

Book Synopsis CAPA in the Pharmaceutical and Biotech Industries by : J Rodriguez

Download or read book CAPA in the Pharmaceutical and Biotech Industries written by J Rodriguez and published by Elsevier. This book was released on 2015-12-08 with total page 250 pages. Available in PDF, EPUB and Kindle. Book excerpt: CAPA in the Pharmaceutical and Biotech Industries: How to Implement an Effective Nine Step Program contains the most current information on how to implement, develop, and maintain an effective Corrective Action and Preventive Action (CAPA) and investigation program using a nine step closed-loop process approach for medical devices and pharmaceutical and biologic manufacturers, as well as any anyone who has to maintain a quality system.This book addresses how companies often make the mistake of fixing problems in their processes by revising procedures or, more commonly, by retraining employees that may or may not have caused the problem. This event-focused fix leads to the false assumption that the errors have been eradicated and will be prevented in the future. The reality is that the causes of the failure were never actually determined, therefore the same problem will recur over and over. CAPA is a complete system that collects information regarding existing and potential quality problems. It analyzes and investigates the issues to identify the root cause of nonconformities. It is not just a quick-fix, simple approach, it is a process and has to be understood throughout organizations. - Provides an understanding of the principles and techniques involved in the effective implementation of a CAPA program, from the identification of the problem, to the verification of preventive action - Emphasis is placed on the practical aspects of how to perform failure investigations and root cause analysis through the use of several types of methodologies, all explained in detail - Provides effective methods to use with a Corrective Action system to help quality professionals identify costly issues and resolve them quickly and appropriately


CAPA in the Pharmaceutical and Biotech Industries Related Books

CAPA in the Pharmaceutical and Biotech Industries
Language: en
Pages: 250
Authors: J Rodriguez
Categories: Medical
Type: BOOK - Published: 2015-12-08 - Publisher: Elsevier

DOWNLOAD EBOOK

CAPA in the Pharmaceutical and Biotech Industries: How to Implement an Effective Nine Step Program contains the most current information on how to implement, de
From Plant Genomics to Plant Biotechnology
Language: en
Pages: 275
Authors: Palmiro Poltronieri
Categories: Science
Type: BOOK - Published: 2013-08-31 - Publisher: Elsevier

DOWNLOAD EBOOK

With the appearance of methods for the sequencing of genomes and less expensive next generation sequencing methods, we face rapid advancements of the -omics tec
Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals
Language: en
Pages: 370
Authors: Tim Sandle
Categories: Medical
Type: BOOK - Published: 2013-10-31 - Publisher: Elsevier

DOWNLOAD EBOOK

Failure to adequately control any microbial challenge associated within process or product by robust sterilisation will result in a contaminated marketed produc
Formulation Tools for Pharmaceutical Development
Language: en
Pages: 304
Authors: J E Aguilar
Categories: Medical
Type: BOOK - Published: 2013-09-30 - Publisher: Elsevier

DOWNLOAD EBOOK

A range of new and innovative tools used for preformulation and formulation of medicines help optimize pharmaceutical development projects. Such tools also assi
Computer-Aided Applications in Pharmaceutical Technology
Language: en
Pages: 300
Authors: Jelena Duris
Categories: Computers
Type: BOOK - Published: 2013-04-10 - Publisher: Elsevier

DOWNLOAD EBOOK

Research and development in the pharmaceutical industry is a time-consuming and expensive process, making it difficult for newly developed drugs to be formulate